In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the one-year delay to clinical laboratory payment cuts recently passed by Congress and the importance of responding to the FDA’s proposed rule on laboratory-developed tests.

Specific discussion points include:

• How Congress passed the short-term spending package on Nov. 15 that included a one-year reprieve from planned Medicare cuts to laboratory services, and what this means moving forward.
• Why it is critical to submit constructive comments in response to the FDA’s proposed rule on laboratory-developed tests before the Dec. 4 deadline.
• What specific information would be helpful for laboratories to include in their comments to the FDA.